← IDEXX LABORATORIES INC /DE IDXX
Market Price
$551.03
Market Cap
$44.72B
P/E Ratio
42.13
Revenue (FY 2025)
↑10.4% YoY
$4.30B
3-Yr CAGR: 8.5%
Net Income
↑19.3% YoY
$1.06B
Net Margin: 24.6%
Free Cash Flow
↑30.8% YoY
$1.06B
FCF Yield: 2.36%
EPS (Diluted)
↑22.6% YoY
$13.08
Basic: $13.17
Return on Equity
Efficiency
66.0%
ROA: 74.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (IDXX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,775.4M | — | $975.4M | $222.0M | — | $2.44 | — | $334.6M | $269.8M | — |
| FY 2017 | $1,969.1M | +10.9% | $1,097.4M | $263.1M | +18.5% | $2.94 | +20.5% | $373.3M | $298.9M | +10.8% |
| FY 2018 | $2,213.2M | +12.4% | $1,241.5M | $377.0M | +43.3% | $4.26 | +44.9% | $400.1M | $284.3M | -4.9% |
| FY 2019 | $2,406.9M | +8.8% | $1,365.5M | $427.7M | +13.4% | $4.89 | +14.8% | $459.2M | $304.2M | +7.0% |
| FY 2020 | $2,706.7M | +12.5% | $1,571.0M | $581.8M | +36.0% | $6.71 | +37.2% | $648.1M | $541.1M | +77.9% |
| FY 2021 | $3,215.4M | +18.8% | $1,889.4M | $744.8M | +28.0% | $8.60 | +28.2% | $755.5M | $636.0M | +17.5% |
| FY 2022 | $3,367.3M | +4.7% | $2,004.3M | $679.1M | -8.8% | $8.03 | -6.6% | $543.0M | $394.1M | -38.0% |
| FY 2023 | $3,661.0M | +8.7% | $2,190.0M | $845.0M | +24.4% | $10.06 | +25.3% | $906.5M | $772.9M | +96.1% |
| FY 2024 | $3,897.5M | +6.5% | $2,378.9M | $887.9M | +5.1% | $10.67 | +6.1% | $929.0M | $808.1M | +4.6% |
| FY 2025 | $4,303.7M | +10.4% | $2,659.6M | $1,059.5M | +19.3% | $13.08 | +22.6% | $1,181.8M | $1,057.1M | +30.8% |
Valuation
Market Price
$551.03
Market Cap
$44.72B
Enterprise Value
$44.99B
P/E Ratio
42.13
P/B Ratio
27.08
FCF Yield
2.36%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
61.80%
Operating Margin
31.60%
Net Margin
24.62%
Return on Equity (ROE)
65.99%
Return on Assets (ROA)
74.94%
Asset Turnover
3.04x
Revenue 3-Yr CAGR
8.52%
Financial Health & Liquidity
Current Ratio
2.67
Cash Ratio
0.34
Debt / Equity
0.280
Debt / Assets
0.318
Cash & Equivalents
$180.07M
Total Debt
$449.84M
Book Value / Share
$20.35
Cash Flow Efficiency
Operating Cash Flow
$1.18B
Capital Expenditures (CapEx)
$124.68M
Free Cash Flow
$1.06B
OCF / Revenue
27.46%
FCF / Revenue
24.56%
FCF 3-Yr CAGR
38.94%
Per Share Metrics
EPS (Diluted)
$13.08
EPS (Basic)
$13.17
Dividends / Share
N/A
Book Value / Share
$20.35
EPS YoY Growth
22.59%
Balance Sheet (FY 2025)
Total Assets
$1.41B
Total Liabilities
$530.15M
Stockholders' Equity
$1.61B
Current Assets
$1.41B
Current Liabilities
$530.15M